Idarubicin Hydrochloride Injection, Solution
Product Images NDC 71288-186

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Idarubicin Hydrochloride (NDC 71288-186). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 10 mg per 10 mL Carton)

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 10 mg per 10 mL Carton)
Packaging label for Idarubicin Hydrochloride Injection, USP 10 mg per 10 mL (1 mg per mL) in a single-dose vial. The label includes warnings of cytotoxicity and specifies intravenous use only. The product is sterile and isotonic. It is labeled by Meitheal Pharmaceuticals Inc. with storage instructions and cautionary statements, including protection from light and refrigeration requirements.*
FDA Label Image

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 10 mg per 10 mL Container Label)

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 10 mg per 10 mL Container Label)
Label for Idarubicin Hydrochloride Injection, USP 10 mg per 10 mL (1 mg/mL) intravenous solution. It is a 10 mL single-dose vial containing a sterile, isotonic solution. The label includes usage instructions, storage conditions (2 to 8 °C), and warns about severe side effects such as extravasation. The product is manufactured by Meitheal Pharmaceuticals Inc.*
FDA Label Image

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 20 mg per 20 mL Carton)

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 20 mg per 20 mL Carton)
The packaging label for Idarubicin Hydrochloride Injection, USP, 1 mg/mL (20 mg per 20 mL) shows a single-dose vial. The label indicates it is a cytotoxic agent for intravenous use only. The product is sterile, isotonic, and supplied by Meitheal Pharmaceuticals Inc. The label includes storage instructions, a barcode, and handling warnings.*
FDA Label Image

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 20 mg per 20 mL Container Label)

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 20 mg per 20 mL Container Label)
Label for Idarubicin Hydrochloride Injection, USP 20 mg per 20 mL (1 mg per mL) intravenous solution in a 20 mL single-dose vial. The label states sterile isotonic solution for intravenous use only, with detailed ingredient information and usage warnings. Labeler is Meitheal Pharmaceuticals Inc.*
FDA Label Image

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 5 mg per 5 mL Carton)

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 5 mg per 5 mL Carton)
Packaging label for Idarubicin Hydrochloride Injection, USP 1 mg/mL (5 mg per 5 mL) in a 5 mL single-dose vial. The label states it is for intravenous use only, cytotoxic, sterile, and isotonic. It is manufactured by Meitheal Pharmaceuticals Inc., with storage instructions and warnings included on the side panel.*
FDA Label Image

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 5 mg per 5 mL Container Label)

Package Label.principal Display Panel (Idarubicin Hydrochloride Injection, USP 5 mg per 5 mL Container Label)
Label for Idarubicin Hydrochloride Injection, USP showing a 5 mg per 5 mL (1 mg per mL) concentration in a 5 mL single-dose vial. The label states it is for intravenous use only and is sterile isotonic solution. It includes storage instructions to refrigerate, usage directions to discard unused portions, and warnings about severe cellulitis and ulceration. The label is from Meitheal Pharmaceuticals Inc.*
FDA Label Image

Structural Formula (Idarubicin Structure)

Structural Formula (Idarubicin Structure)
Chemical structure of Idarubicin Hydrochloride, illustrating its molecular arrangement including aromatic rings, hydroxyl groups, and hydrochloride salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.